Epirubicin and Cyclophosphamide Compared With Epirubicin and Paclitaxel in Treating Women With Metastatic Breast Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

704

Participants

Timeline

Start Date

December 31, 1996

Study Completion Date

November 30, 2005

Conditions
Breast Cancer
Interventions
DRUG

cyclophosphamide

DRUG

epirubicin hydrochloride

DRUG

paclitaxel

Trial Locations (19)

7925

Groote Schuur Hospital, Cape Town, Cape Town

B15 2TT

University Birmingham, Birmingham

BS2 8BJ

Bristol Royal Hospital for Sick Children, Bristol

BS2 8ED

Bristol Oncology Centre, Bristol

DE1 2QY

Derbyshire Royal Infirmary, Derby

LS16 6QB

Cookridge Hospital, Leeds

LE1 5WW

University Hospitals of Leicester, Leicester

W1N 8AA

Middlesex Hospital- Meyerstein Institute, London

L63 4JY

Clatterbridge Centre for Oncology NHS Trust, Merseyside

NE4 6BE

Newcastle General Hospital, Newcastle upon Tyne

HA6 2RN

Mount Vernon Hospital, Northwood

NR1 3SR

Norfolk & Norwich Hospital, Norwich

NG5 1PB

Nottingham City Hospital NHS Trust, Nottingham

0X3 7LJ

Oxford Radcliffe Hospital, Oxford

SM2 5PT

Royal Marsden Hospital, Sutton

Unknown

Southend General Hospital, Westcliff-on-Sea

Royal Hospital for Sick Children, Edinburgh

G11 6NT

Beatson Oncology Centre, Glasgow

PR2 9HT

Royal Preston Hospital, Preston

Sponsors
All Listed Sponsors
lead

Medical Research Council

OTHER_GOV